November 13, 2020
Tips for building financial success with CBD for your pharmacy.
November 12, 2020
As the use of CBD-containing products continues to rise, pharmacists need to be familiar with the clinical implications of CBD use, especially in patients who use other pharmacologically active substances.
November 09, 2020
What pharmacists need to consider before selling CBD in their stores.
October 26, 2020
By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
October 21, 2020
CBD and its impacts on a protective peptide show that the cannabinoid may reduce lung inflammation and damage.
August 04, 2020
The FDA approved a cannabidiol oral solution treatment (Epidiolex, Greenwich Biosciences) for seizures associated with tuberous sclerosis complex.
July 31, 2020
Our first episode of our latest Cannabis Series is focused on the burgeoning medical marijuana landscape, featuring FDA's guidelines and research on the diverse benefits of cannabis as medicine.
July 27, 2020
Responding to growing interest by industry stakeholders, the agency has offered draft guidance outlining quality considerations and other practical recommendations for cannabis and cannabis-derived compounds.
May 30, 2020
A systematic review of medical cannabis and cannabinoid use in oncology care demonstrated varied results.
April 07, 2020
Cannabidiol oral solution (Epidiolex, GW Pharmaceuticals) is no longer considered a controlled substance.
